Rapid Assessment of World Bank COVID-19 Multi-Phase Programmatic Approach

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $0
  • Funder

    Vital Strategies
  • Principal Investigator

    . Kate Molesworth, Peter Steinmann
  • Research Location

    Ethiopia, Cambodia
  • Lead Research Institution

    Swiss Tropical and Public Health Institute
  • Research Priority Alignment

    N/A
  • Research Category

    N/A

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The World Bank supports around 100 country responses to COVID-19 through loans and grants totalling over USD 6 billion. Funding is based either on the Multi-phase Programmatic Approach (MPA) model or through restructuring existing projects. The WB intends to assess the pertinence of the original proposals, which had been developed based on information available at that time, and under considerable time constraints. The WB also wants to document whether the funds are effectively supporting the pandemic response as intended, complementing domestic and other international funding and, being managed according to agreed standards. Special consideration is on the impact of spending on COVID-19 response and broader epidemic preparedness. Aim: to assess how far the Covid-19 projects under the MPA framework have reached their overarching objective to contribute to prevention, detection and response to COVID-19 and strengthen national health and surveillance systems, complemented by efforts to alleviate the economic burden of containment measures on households. Objective: describe WB financing within overall national responses and indicate ways to improve the quality, effectiveness and impact of program design, and rationalize the choice of intervention in the light of the latest epidemiological and scientific evidence, and strengthen implementation in a timely manner.